Hampton: Now, Vanguard’s also collaborating with Wellington and Blackstone to combine public and private assets into multi-asset investments. What do you make of this, and does this fit in Vanguard’s ...
Novo Nordisk said it achieved 200,000 weekly prescription in the U.S. for the Wegovy pill by mid-April, which it said was the fastest take-up ever in the GLP-1 category of drugs in the U.S., which ...
We own our home, which is paid off.' "We were considering a VA loan, to have the funds for updates without touching our CD or money-market fund." (Photo subjects are models.) Dear Quentin, My husband ...
Inflows to dividend ETFs came just in time for dividend stocks to lag amid a rebound in the broad equity market. In April, ...
Rational’s multifunctional cooking appliances enjoy a 50% market share, yet its runway opportunity remains lengthy since the majority of professional kitchens still use traditional cooking appliances.
Lazard Asset Management expects a renewed steepening of the government bond yield curve , particularly in the eurozone. This would be a logical consequence of ambitious fiscal programs, tight labor ...
Electronic Arts has agreed to go private in 2026, and we expect the firm to receive the necessary regulatory approvals.
Dow Jones Top Energy Headlines at 4 AM ET: Orsted's Earnings Rise on Jump in Offshore Generation | This ... The renewable-energy company's earnings before interest, taxes, depreciation and ...
The maximum Social Security check at full retirement age (67) is already $4,152 per month (or $49,824 a year) for 2026. The only way to go above this is to claim at age 70 for a maximum of $5,181 per ...
Dow Jones Top Markets Headlines at 3 AM ET: Asian Stocks Advance Amid Hopes for U.S.-Iran Peace Deal | This ... Equity markets across Asia were higher, with South Korea's Kospi hitting a record high ...
Novo Nordisk said it achieved 200,000 weekly prescription in the U.S. for the Wegovy pill by mid-April, which it said was the fastest take-up ever in the GLP-1 category of drugs in the U.S., which ...
Wegovy maker Novo Nordisk lifted full-year guidance on surging demand for its new weight-loss pill. The Danish drugmaker said total prescriptions for the Wegovy pill reached around 1.3 million in the ...